-
North Carolina Neighbors Fear Mesothelioma After Learning of Asbestos Dumping
Residents of Davidson, North Carolina are suddenly dealing with very real concerns about malignant mesothelioma and other asbestos-related diseases after learning that their neighborhood was build adjacent to and above an asbestos dumping site. Though officials from the Division of Waste Management held a meeting to discuss long-term plans and provide assurances, few of the
-
European Mesothelioma Victims Demand Justice From Those Responsible
Though American society is frequently criticized for being overly litigious, it is also true that the U.S. justice system serves as a model for the rest of the world, and this is increasingly true when it comes to seeking justice for those diagnosed with malignant mesothelioma. In the United States, victims of asbestos exposure have
-
Occupational Medicine Study Links Cosmetic Talc to Malignant Mesothelioma
As mesothelioma lawsuits against Johnson & Johnson and other cosmetic talc companies continue being filed, a study has just been published in the official journal of the American College of Occupational and Environmental Medicine definitively linking asbestos found in these products to the illness.
-
Newly Launched Mesothelioma Trial To Test Pre-Surgical Combination Therapy
Memorial Sloan Kettering Cancer Center in New York City is a world leader in mesothelioma research, and the facility has recently launched a clinical trial that will study the efficacy of combining an immunotherapy drug with chemotherapy prior to patients undergoing surgical removal of their tumors. The hope is that patient survival time will be
-
Spanish Study Identifies Novel Drug Combination for Treatment of Mesothelioma
Researchers from the Spanish National Cancer Research Centre have just revealed successful treatment of malignant mesothelioma in laboratory animals through a novel combination of drugs that are already in use in treatment of other tumors. The scientists say that their discovery stemmed from an analysis of the rare asbestos-related form of cancer’s key molecular processes.
-
Johnson & Johnson Agrees to Rare Settlement in Midst of Mesothelioma Lawsuit
Johnson & Johnson stands accused of causing malignant mesothelioma and ovarian cancer in thousands of victims, but the company has stood firm in its arguments against all claims and has continued defending itself, even with over 17,000 cases pending. So it was notable that the company agreed to pay a California woman a settlement reportedly
-
Mesothelioma Among Cancers That Revisited Therapy May Target
Malignant mesothelioma is one of the most challenging forms of cancers to treat. Caused by exposure to cancer, the tumors that form in the lining of the peritoneal or pleural cavity are notoriously resistant to chemotherapy and other traditional treatments. Ironically, it is this very resistance that puts mesothelioma high on the list of possible
-
Women’s Health Study Examines Link Between Incidence of Mesothelioma and Ovarian Cancer
Asbestos has long been known to cause malignant mesothelioma, a rare and fatal form of cancer that is diagnosed in roughly 3,500 Americans each year. But recent reports of the carcinogenic material contaminating talc-based personal care products have led to closer examination of its role in the development of ovarian cancer, and that in turn
-
Latest Immunotherapy Research Provides New Option for Mesothelioma Treatment
Researchers from the University of Basel have uncovered a new strategy to strengthen the response to immunotherapy, and their discovery provides a new approach for those diagnosed with malignant mesothelioma.
-
Facing The New Year With Malignant Mesothelioma
For those who have been diagnosed with malignant mesothelioma — and those who love them — the holidays can be particularly challenging. While those around you are raucously celebrating the New Year and wishing each other all good things, patients and their families look forward with a certainty that the coming year will bring more
-
German Researchers Deem Heated Chemotherapy Safe Option for Pleural Mesothelioma
Heated chemotherapy administered following removal of cancerous tumors has long been viewed as an effective treatment for patients diagnosed with peritoneal malignant mesothelioma, but its use in pleural mesothelioma has not been as accepted. But physicians from the University of Munich recently completed a study that led them to conclude that the procedure, known as
-
Researchers Confirm PD-L1 Role In Mesothelioma
When you’re dealing with an extremely rare form of cancer like malignant mesothelioma, it would make sense to assume that everybody with the disease will receive similar treatments and experience similar progression of their disease. But even in a condition that strikes just 3,500 people per year, there can be wide variations, and French researchers
-
Court Upholds Mesothelioma Victim’s Multi-Million Dollar Award
When a person is diagnosed with malignant mesothelioma, they are faced with many difficult decisions. Though the first and most important of these are the choices that must be made regarding treatment, eventually the question of how to pay for treatments will follow, as well as how the family will survive financially once the patient
-
Mesothelioma Researchers Identify New Biomarker for Tumor Progression
An international team of mesothelioma researchers has discovered a novel target in patients diagnosed with the rare asbestos-related cancer that may lead to improved disease management in the future. Publishing their findings in the December 19th, 2019 issue of the Journal of Cellular Physiology, scientists from Thomas Jefferson University, Sbarro Institute for Cancer Research and Molecular
-
Congressional Hearings Regarding Asbestos in Talc Features Mesothelioma Victim’s Testimony
A subcommittee of the House of Representatives’ Committee on Oversight and Reform met last week to hear testimony from a mesothelioma victim and others about the safety of cosmetic talc powder products. There is a significant concern about asbestos contamination in these products following thousands of lawsuits being filed against the manufacture of Johnson &
-
National Institutes of Health Grants $2.6 Million to Mesothelioma Researchers
Mesothelioma researchers from the University of Hawaii Cancer Center got a big boost from the National Institutes of Health (NIH) this week when they got word they’d been awarded a five-year, $2.6 million grant. The team has been studying the role of the BAP1 gene in human cancer development and cell metabolism, and hopes that
-
National Cancer Institute Study Finds Immunotherapy Vaccine Impacts Mesothelioma
When a mesothelioma patient learns that their cancer is inoperative, it often means that they have few options left. But according to a recent study conducted by researchers at the National Cancer Institute, a vaccine known as CRS-207 which is built on bacteria associated with food poisoning may offer hope for longer survival.
-
Tiles Used in Home Renovation Blamed for Man’s Mesothelioma Death
Santo Lanza died of malignant mesothelioma on March 4, 2014, just two months after he filed a lawsuit against American Biltrite, the manufacturer of tiles that he used in his home renovation in Brooklyn, New York and before he could be deposed. But the man’s lifelong habit of enlisting the help of his son John
-
Taipei University Finds Melodic Method of Easing Mesothelioma Pain
No matter whether a victim of asbestos exposure has been diagnosed with peritoneal mesothelioma, pleural mesothelioma, or other related illnesses such as asbestosis or ovarian cancer, pain is a constant companion. But a study conducted at Taipei Medical University in Taipei, Japan has revealed an effective, inexpensive and easily accessible source of relief: listening to
-
New Study Reveals Worse Mesothelioma Prognosis With Higher Expression of CD70 Protein
Mesothelioma patients rely on their physicians to guide their decisions about the best treatment option for their disease, and physicians use a variety of tools in making the best possible determination for each individual patient. Among the specific elements that physicians look at are the biomarkers found in the patient’s blood and tumor, as these
